First Long Island Investors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-793
Closed -$275K – 61
2021
Q2
$275K Hold
793
– – 0.02% 58
2021
Q1
$222K Buy
+793
New +$214K 0.02% 60
2020
Q4
– Sell
-793
Closed -$225K – 62
2020
Q3
$225K Hold
793
– – 0.02% 58
2020
Q2
$212K Sell
793
-36
-4% -$10.8K 0.02% 58
2020
Q1
$262K Hold
829
– – 0.04% 60
2019
Q4
$246K Buy
+829
New +$230K 0.03% 68
2019
Q1
– Sell
-831
Closed -$250K – 73
2018
Q4
$250K Hold
831
– – 0.04% 64
2018
Q3
$294K Hold
831
– – 0.04% 66
2018
Q2
$241K Hold
831
– – 0.03% 68
2018
Q1
$228K Sell
831
-5
-0.6% -$1.55K 0.03% 69
2017
Q4
$266K Buy
836
+5
+0.6% +$1.6K 0.04% 67
2017
Q3
$260K Hold
831
– – 0.04% 67
2017
Q2
$226K Buy
+831
New +$220K 0.04% 71

Other funds holding BIIB

First Long Island Investors's BIIB Position: Q3 2021 in Review

First Long Island Investors sold out of Biogen (BIIB) in Q3 2021, closing a stake of 793 shares — an estimated $275K sold.

First Long Island Investors first reported a position in BIIB in Q2 2017 and held it in 13 quarters. The position peaked at $294K in Q3 2018. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • First Long Island Investors reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • First Long Island Investors sold 793 Biogen shares in Q3 2021, an estimated $275K.
  • First Long Island Investors first reported a position in Biogen in Q2 2017 and held it in 13 quarters.
  • First Long Island Investors's Biogen position peaked at $294K in Q3 2018.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on First Long Island Investors's 13F filing for Q3 2021, filed 1 Nov 2021.